ATE253066T1 - Imidazotriazinderivate als gaba rezeptor-liganden - Google Patents
Imidazotriazinderivate als gaba rezeptor-ligandenInfo
- Publication number
- ATE253066T1 ATE253066T1 AT00954717T AT00954717T ATE253066T1 AT E253066 T1 ATE253066 T1 AT E253066T1 AT 00954717 T AT00954717 T AT 00954717T AT 00954717 T AT00954717 T AT 00954717T AT E253066 T1 ATE253066 T1 AT E253066T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor ligands
- gaba receptor
- optionally substituted
- derivatives
- imidazotriazine
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 2
- XZLIYCQRASOFQM-UHFFFAOYSA-N 5h-imidazo[4,5-d]triazine Chemical class N1=NC=C2NC=NC2=N1 XZLIYCQRASOFQM-UHFFFAOYSA-N 0.000 title 1
- 102000005915 GABA Receptors Human genes 0.000 title 1
- 108010005551 GABA Receptors Proteins 0.000 title 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 102000027484 GABAA receptors Human genes 0.000 abstract 1
- 108091008681 GABAA receptors Proteins 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 150000001602 bicycloalkyls Chemical group 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000004892 pyridazines Chemical class 0.000 abstract 1
- 125000005415 substituted alkoxy group Chemical group 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9919957.2A GB9919957D0 (en) | 1999-08-23 | 1999-08-23 | Therapeutic agents |
| PCT/GB2000/003199 WO2001014377A1 (en) | 1999-08-23 | 2000-08-17 | Imidazo-triazine derivatives as ligands for gaba receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE253066T1 true ATE253066T1 (de) | 2003-11-15 |
Family
ID=10859670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00954717T ATE253066T1 (de) | 1999-08-23 | 2000-08-17 | Imidazotriazinderivate als gaba rezeptor-liganden |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6608062B1 (https=) |
| EP (1) | EP1212324B1 (https=) |
| JP (1) | JP2003507479A (https=) |
| AT (1) | ATE253066T1 (https=) |
| AU (1) | AU775008B2 (https=) |
| CA (1) | CA2380452C (https=) |
| DE (1) | DE60006260T2 (https=) |
| ES (1) | ES2208404T3 (https=) |
| GB (1) | GB9919957D0 (https=) |
| WO (1) | WO2001014377A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
| GB0210127D0 (en) * | 2002-05-02 | 2002-06-12 | Merck Sharp & Dohme | Therapeutic agents |
| AU2003252499B2 (en) * | 2002-07-12 | 2007-11-08 | Japan Science And Technology Agency | Drugs for improving the prognosis of brain injury and a method of screening the same |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP1928437A2 (en) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| AU2006327300A1 (en) | 2005-12-20 | 2007-06-28 | Astrazeneca Ab | Substituted Cinnoline derivatives as GABAa-receptor modulators and method for their synthesis |
| US7465795B2 (en) | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| EP2068872A1 (en) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| GB0622472D0 (en) * | 2006-11-10 | 2006-12-20 | Addex Pharmaceuticals Sa | Novel heterocyclic derivatives |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US20240327413A1 (en) * | 2021-06-29 | 2024-10-03 | Zomagen Biosciences Ltd | Nlrp3 modulators |
| IL310992A (en) * | 2021-08-25 | 2024-04-01 | Ptc Therapeutics Inc | NLRP3 inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3422194A (en) * | 1967-08-15 | 1969-01-14 | Smithkline Corp | The treatment of depression with imidazo(1,2-b)-as-triazines and compositions thereof |
| ES2194205T3 (es) | 1996-07-25 | 2003-11-16 | Merck Sharp & Dohme | Derivados de triazolo-piridazina sustituidos como ligandos para los receptores gaba. |
| CA2346289A1 (en) * | 1998-10-16 | 2000-04-27 | Merck Sharp & Dohme Limited | Pyrazolo-triazine derivatives as ligands for gaba receptors |
-
1999
- 1999-08-23 GB GBGB9919957.2A patent/GB9919957D0/en not_active Ceased
-
2000
- 2000-08-17 CA CA002380452A patent/CA2380452C/en not_active Expired - Fee Related
- 2000-08-17 WO PCT/GB2000/003199 patent/WO2001014377A1/en not_active Ceased
- 2000-08-17 AU AU67077/00A patent/AU775008B2/en not_active Ceased
- 2000-08-17 US US10/069,437 patent/US6608062B1/en not_active Expired - Fee Related
- 2000-08-17 DE DE60006260T patent/DE60006260T2/de not_active Expired - Lifetime
- 2000-08-17 AT AT00954717T patent/ATE253066T1/de not_active IP Right Cessation
- 2000-08-17 ES ES00954717T patent/ES2208404T3/es not_active Expired - Lifetime
- 2000-08-17 JP JP2001518708A patent/JP2003507479A/ja not_active Withdrawn
- 2000-08-17 EP EP00954717A patent/EP1212324B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1212324A1 (en) | 2002-06-12 |
| ES2208404T3 (es) | 2004-06-16 |
| GB9919957D0 (en) | 1999-10-27 |
| US6608062B1 (en) | 2003-08-19 |
| WO2001014377A1 (en) | 2001-03-01 |
| AU775008B2 (en) | 2004-07-15 |
| EP1212324B1 (en) | 2003-10-29 |
| CA2380452C (en) | 2008-10-28 |
| AU6707700A (en) | 2001-03-19 |
| DE60006260T2 (de) | 2004-07-29 |
| DE60006260D1 (de) | 2003-12-04 |
| JP2003507479A (ja) | 2003-02-25 |
| CA2380452A1 (en) | 2001-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE284403T1 (de) | Triazolopyridazinderivate als liganden für gaba- rezeptoren | |
| GB9927687D0 (en) | Therapeutic agents | |
| DE60006260D1 (de) | Imidazotriazinderivate als gaba rezeptor-liganden | |
| GB0117277D0 (en) | Therapeutic agents | |
| ATE338758T1 (de) | Imidazopyrimidin-derivate als liganden für gaba- rezeptoren | |
| AU1253002A (en) | Imidazo-triazine derivatives as ligands for gaba receptors | |
| BG104671A (en) | Triazolo-pyridazine derivatives as ligands for gaba receptors | |
| GB0212048D0 (en) | Therapeutic agents | |
| DE69911374D1 (de) | Triazolopiridazinederivate als gaba rezeptor-liganden | |
| BG108166A (en) | Imidazo-pyrimidine derivatives as liigands for gaba receptors | |
| ATE255109T1 (de) | Imidazopyridinderivate als gaba rezeptor liganden | |
| ATE335741T1 (de) | 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren | |
| BG103112A (en) | Substituted triazolo-pyuridazin derivatives as ligands for gaba receptors | |
| DE69936998D1 (de) | Pyrazolotriazinderivate als gaba-rezeptorliganden | |
| DE60001983D1 (de) | Bicyclische und tricyclische heteroaromatische verbindungen | |
| CY1106393T1 (el) | Μεθοδος παρασκευης υποκατεστημενων 5-αμινο-πυραζολο [4,3-ε]-1,2,4-τριαζολο [1,5-c]πυριμιδινων | |
| Sugimori et al. | Synthesis and antitumor activity of ring A-and F-modified hexacyclic camptothecin analogues | |
| CA2257222A1 (en) | Amide derivatives | |
| BG105152A (en) | A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom | |
| PE44299A1 (es) | Derivados sustituidos de triazolo-piridacina como ligandos para receptores gaba | |
| CA2260774A1 (en) | Substituted triazolo-pyridazine derivatives as ligands for gaba receptors | |
| EP1010699A4 (en) | 5-POSITIONED 3-OXADIAZOLYL-1,6-NAPHTHYRIDIN-2 (1H) -ON DERIVATIVES | |
| JO2312B1 (en) | Imidazo-pyrimidine derivatives as associative groups of JABA receptors | |
| WO2002024641A1 (en) | Tricyclic indole compounds having affinity for serotonin receptor | |
| TR200002100T2 (tr) | GABA reseptörleri için ligandlar olarak triazolo-piridazin türevleri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |